ORIGINAL RESEARCH article
Front. Bioeng. Biotechnol.
Sec. Nanobiotechnology
Volume 13 - 2025 | doi: 10.3389/fbioe.2025.1602494
Coupling Enzymatic Digestion with Nanopore Sensing for Low-Abundance EGFR-L858R Mutation Detection
Provisionally accepted- 1Chongqing Medical University, Chongqing, China
- 2Chongqing Institute of Green and Intelligent Technology, Chinese Academy of Sciences (CAS), Chongqing, Chongqing Municipality, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Single nucleotide variants (SNVs) serve as crucial biomarkers for tumor diagnosis, treatment, and prognosis. However, their detection remains challenging due to the low mutation frequency and limited abundance. In this study, we developed a sensitive and efficient SNV detection method combining T7 endonuclease I (T7E1) digestion and nanopore detection. The assay was designed to detect the L858R mutation in exon 21 of the EGFR gene, a key driver mutation in various cancers. Magnetic bead probes were utilized to capture and purify target DNA, followed by enzymatic cleavage and nanopore detection. The optimal nanopore detection voltage was determined to be 500 mV, ensuring a clear and reproducible signal for identifying digested DNA fragments. This approach enabled the detection of L858R mutations with a sensitivity as low as 0.1%. Compared to conventional sequencing and digital PCR, our method is simple, time-efficient, and cost-effective. This strategy offers a promising platform for SNV detection, providing a valuable tool for tumor diagnosis and personalized treatment.
Keywords: Single nucleotide variant, EGFR L858R, T7E1 digestion, Nanopore detection, Magnetic bead separation, tumor biomarker
Received: 29 Mar 2025; Accepted: 21 Aug 2025.
Copyright: © 2025 Yan, Wang, Yin, Niu and Luo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Ling Yan, Chongqing Medical University, Chongqing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.